Comparison of the efficacy of a second intravenous or subcutaneous anti-TNF in the treatment of ulcerative colitis: Real-world data from the ENEIDA registry

被引:0
|
作者
Torres-Rodriguez, P. [1 ]
Canete, F. [1 ,2 ]
Calafat, M. [1 ]
Sanchez-Aldehuelo, R. [3 ]
Rivero, M. [4 ,5 ]
Iborra, M. [2 ,6 ]
Gonzalez-Vivo, M. [7 ]
Vera, I. [8 ]
de Castro, L. [9 ]
Bujanda, L. [2 ,10 ,11 ,12 ]
Barreiro-de Acosta, M. [13 ]
Calvet, X. [2 ,14 ]
Benitez, J. M. [15 ,16 ]
Llorente, M. [17 ]
Suris, G. [18 ]
Arias-Garcia, L. [19 ]
David, M. [20 ]
Castano-Garcia, A. [21 ]
Garcia-Alonso, F. J. [22 ]
Rufo, L. [23 ]
Ferrer, J. A. [24 ]
Camo, P. [25 ]
Gisbert, J. P. [2 ,26 ]
Huguet, J. M. [27 ]
Pajares, R. [28 ]
Morales, V. [29 ]
Llao, J. [30 ]
Rodriguez, A. [31 ]
Rodriguez, C. [32 ]
Navarro, M. [33 ]
Gomollon, F. [2 ,34 ]
Carrillo-Palau, M. [35 ]
Sese, E. [36 ]
Almela, P. [37 ]
Ramirez de la Piscina, P. [38 ]
Rodriguez-Lago, I. [39 ]
Papo, M. [40 ]
Vela, M. [41 ]
Manosa, M. [1 ,2 ]
Domenech, E. [1 ,2 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona, Spain
[2] CIBEREHD, Dept Gastroenterol & Hepatol, Madrid, Spain
[3] Hosp Univ Ramon & Cajal, Dept Gastroenterol & Hepatol, Madrid, Spain
[4] Hosp Univ Marques de Valdecilla, Dept Gastroenterol, Santander, Spain
[5] IDIVAL, Dept Gastroenterol, Santander, Spain
[6] Hosp Univ & Politecn La Fe, Dept Gastroenterol, Valencia, Spain
[7] Hosp del Mar, Dept Gastroenterol, Barcelona, Spain
[8] Hosp Univ Puerta de Hierro, Dept Gastroenterol, Majadahonda, Spain
[9] Complejo Hosp Univ Vigo, Dept Gastroenterol, Vigo, Spain
[10] Hosp Univ Donostia, Dept Gastroenterol, San Sebastian, Spain
[11] Univ Pais Vasco UPV EHU, Dept Gastroenterol, San Sebastian, Spain
[12] Inst Biodonostia, Dept Gastroenterol, San Sebastian, Spain
[13] Complexo Hosp Univ Santiago, Dept Gastroenterol, Santiago De Compostela, Spain
[14] Corp Sanitaria Univ Parc Tauli, Dept Gastroenterol, Sabadell, Spain
[15] Hosp Univ Reina Sofia, Dept Gastroenterol, Cordoba, Spain
[16] IMIBIC, Dept Gastroenterol, Cordoba, Spain
[17] Hosp Univ Miguel Servet, Dept Gastroenterol & Hepatol, Zaragoza, Spain
[18] Hosp Univ Bellvitge, Dept Gastroenterol, Lhospitalet De Llobregat, Spain
[19] Hosp Univ Burgos, Dept Gastroenterol, Burgos, Spain
[20] Consorci Sanitari Terrassa, Dept Gastroenterol, Terrassa, Spain
[21] Hosp Univ Cent Asturias, Dept Gastroenterol, Oviedo, Spain
[22] Hosp Univ Rio Hortega, Dept Gastroenterol, Valladolid, Spain
[23] Hosp Gen Univ Ciudad Real, Dept Gastroenterol, Ciudad Real, Spain
[24] Hosp Univ Fdn Alcorcon, Dept Gastroenterol, Madrid, Spain
[25] Hosp Gen San Jorge, Dept Gastroenterol, Huesca, Spain
[26] Hosp Univ La Princesa, Dept Gastroenterol, Madrid, Spain
[27] Hosp Gen Univ Valencia, Dept Gastroenterol, Valencia, Spain
[28] Hosp Univ Infanta Sofia, Dept Gastroenterol, Madrid, Spain
[29] Hosp Gen Granollers, Dept Gastroenterol & Hepatol, Granollers, Spain
[30] Althaia Xarxa Assistencial Univ Manresa, Dept Gastroenterol, Manresa, Spain
[31] Hosp Gen Univ Alicante, Dept Gastroenterol, Alicante, Spain
[32] Complejo Hosp Navarra, Dept Gastroenterol, Navarra, Spain
[33] Hosp Moises Broggi, Dept Gastroenterol, St Joan Despi, Spain
[34] Hosp Clin Univ Lozano Blesa, Dept Gastroenterol, Zaragoza, Spain
[35] Hosp Univ Canarias, Dept Gastroenterol, San Cristobal la Laguna, Spain
[36] Hosp Arnau Vilanova, Dept Gastroenterol, Lleida, Spain
[37] Hosp Gen Univ Castellon, Dept Gastroenetol, Castellon de La Plana, Spain
[38] Hosp Univ Alava, Dept Gastroenterol, Vitoria, Spain
[39] Hosp Galdakao Usansolo, Dept Gastroenterol, Galdakao, Spain
[40] Hosp Univ Joan XXIII, Dept Gastroenterol, Tarragona, Spain
[41] Hosp Univ Nuestra Senora de la Candelaria, Dept Gastroenterol, Santa Cruz De Tenerife, Spain
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P544
引用
收藏
页码:S463 / S464
页数:2
相关论文
共 50 条
  • [21] Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive ulcerative colitis patients: Results from the EVOLVE study
    Yarur, A.
    Mantzaris, G.
    Silverberg, M.
    Walshe, M.
    Zezos, P.
    Stein, D.
    Bassel, M.
    Lissoos, T.
    Lopez, C.
    Natsios, A.
    Radulescu, G.
    Patel, H.
    Demuth, D.
    Bressler, B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S400 - S401
  • [22] EFFICACY OF INFLIXIMAB AFTER FAILURE OF SUBCUTANEOUS ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER STUDY
    Streichenberger, Aurelie
    Pariente, Benjamin
    Bozon, Anne
    Arab, Nadia
    Amiot, Aurelien
    Vuitton, Lucine
    Tilmant, Marion
    Nachury, Maria
    Altwegg, Romain
    Delasalle, Thibault
    Gagniere, Charlotte
    Boivineau, Gregoire
    Fumery, Mathurin
    Wils, Pauline
    de Chambrun, Guillaume Pineton
    Hebuterne, Xavier
    Pereira, Bruno
    Bommelaer, Gilles
    Buisson, Anthony
    GASTROENTEROLOGY, 2018, 154 (06) : S834 - S834
  • [23] Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent
    Buisson, A.
    Nachury, M.
    Fumery, M.
    Guilmoteau, T.
    Leclerc, E.
    Altwegg, R.
    Serrero, M.
    Mathieu, N.
    Treton, X.
    Vuitton, L.
    Pereira, B.
    Amiot, A.
    Bouguen, G.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I120 - I120
  • [24] REAL-WORLD MULTICENTER COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT
    Buisson, Anthony
    Nachury, Maria
    Fumery, Mathurin
    Guilmoteau, Thomas
    Leclerc, Eloise
    Altwegg, Romain
    Serrero, Melanie
    Mathieu, Nicolas
    Treton, Xavier
    Vuitton, Lucine
    Pereira, Bruno
    Amiot, Aurelien
    Bouguen, Guillaume
    GASTROENTEROLOGY, 2022, 162 (07) : S604 - S604
  • [25] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE ULCERATIVE COLITIS PATIENTS: RESULTS FROM THE EVOLVE STUDY
    Yarur, Andres J.
    Mantzaris, Gerassimos J.
    Silverberg, Mark S.
    Walshe, Margaret
    Zezos, Petros
    Stein, Dara
    Bassel, Marielle
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Radulescu, Gabriela
    Patel, Haridarshan
    Demuth, Dirk
    Bressler, Brian
    GASTROENTEROLOGY, 2019, 156 (06) : S637 - S638
  • [26] Efficacy of infliximab after failure of subcutaneous anti-TNF agents in patients with ulcerative colitis: A multicentre study
    Streichenberger, A.
    Pariente, B.
    Bozon, A.
    Arab, N.
    Amiot, A.
    Vuitton, L.
    Tilmant, M.
    Nachury, M.
    Altwegg, R.
    Delasalle, T.
    Gagniere, C.
    Gregoire, B.
    Fumery, M.
    Wils, P.
    de Chambrun, G. Pineton
    Hebuterne, X.
    Pereira, B.
    Bommelaer, G.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S291 - S291
  • [27] Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study
    Buisson, A.
    Serrero, M.
    Altwegg, R.
    Guilmoteau, T.
    Bouguen, G.
    Nachury, M.
    Amiot, A.
    Vuitton, L.
    Treton, X.
    Caillo, L.
    Pereira, B.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 707 - 707
  • [28] REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: RESULTS FROM THE TORUS STUDY
    Buisson, Anthony
    Serrero, Melanie
    Altwegg, Romain
    Guilmoteau, Thomas
    Guillaume, Bouguen
    Nachury, Maria
    Amiot, Aurelien
    Vuitton, Lucine
    Treton, Xavier
    Caillo, Ludovic
    Pereira, Bruno
    Fumery, Mathurin
    GASTROENTEROLOGY, 2023, 164 (06) : S4 - S4
  • [29] REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY
    Barberio, B.
    Zingone, F.
    Marinelli, C.
    Maccarone, M. C.
    Ghisa, M.
    Massimi, D.
    Gubbiotti, A.
    D'Inca, R.
    Savarino, E. V.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S118 - S118
  • [30] Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study
    Ko, Yanna
    Paramsothy, Sudarshan
    Yau, Yunki
    Leong, Rupert W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (03) : 292 - 301